Sensipar Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)
Condition:   OsteomalaciaIntervention:   Drug: OsteomalaciaSponsors:   National Institute of Dental and Craniofacial Research (NIDCR);   National Institutes of Health Clinical Center (CC)Recruiting - verified August 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 12, 2012 Category: Research Source Type: clinical trials

Safety & Tolerability of Cinacalcet in Pediatric Subjects With Chronic Kidney Disease & Secondary Hyperparathyroidism
Conditions:   Chronic Kidney Disease;   Hyperparathyroidism, SecondaryIntervention:   Drug: Cinacalcet HClSponsor:   AmgenRecruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2011 Category: Research Source Type: clinical trials

Safety & Tolerability of Cinacalcet in Pediatric Subjects With Chronic Kidney Disease & Secondary Hyperparathyroidism
Conditions:   Chronic Kidney Disease;   Hyperparathyroidism, SecondaryIntervention:   Drug: Cinacalcet HClSponsor:   AmgenRecruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2011 Category: Research Source Type: clinical trials

Study to Evaluate Cinacalcet HCl in Pediatric Subjects With Chronic Kidney Disease
Conditions:   Chronic Kidney Disease;   Hyperparathyroidism, Secondary;   Secondary HyperparathyroidismIntervention:   Drug: Cinacalcet HClSponsor:   AmgenRecruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 20, 2011 Category: Research Source Type: clinical trials

Study to Evaluate Cinacalcet HCl in Pediatric Subjects With Chronic Kidney Disease
Conditions:   Chronic Kidney Disease;   Hyperparathyroidism, Secondary;   Secondary HyperparathyroidismIntervention:   Drug: Cinacalcet HClSponsor:   AmgenRecruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 20, 2011 Category: Research Source Type: clinical trials

Study to Evaluate Cinacalcet HCl in Pediatric Subjects With Chronic Kidney Disease
Conditions:   Chronic Kidney Disease;   Hyperparathyroidism, Secondary;   Secondary HyperparathyroidismIntervention:   Drug: Cinacalcet HClSponsor:   AmgenRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 20, 2011 Category: Research Source Type: clinical trials